Journal of Medicinal Chemistry · 2009 · 48 citations · 44 references
MedicineBioengineeringMolecular BiologyBiomedical ImagingMagnetic Resonance BiophysicsMolecular ImagingContrast AgentsMagnetic Resonance Contrast MechanismsMagnetic Resonance ImagingTargeted Imaging AgentsTheranostic ImagingTumor ImagingContrast Agent DesignContrast Agent SynthesisMagnetic Resonance Imaging Contrast AgentsMatrix Metalloproteinase ImagingMolecular Contrast AgentsParamagnetic Contrast AgentsPeptide-based Imaging AgentsSolubility
We designed and synthesized a novel contrast agent (CA) to image the activity of matrix metalloproteinase-2 (MMP-2) in a tumor, noninvasively using magnetic resonance imaging (MRI). We exploited the concept of solubility-switchable CAs in the design of a protease-modulated CA (PCA), referred to as PCA2-switch. This PCA contains a paramagnetic gadolinium chelate (Gd-DOTA), which was attached to the N-terminus of a MMP-2 cleavable peptide sequence via a hydrophobic chain. The aqueous solubility of the CA depends on the presence of a polyethylene glycol chain (PEG) on the C-terminus of the peptide. Upon proteolytic cleavage of the peptide by MMP-2, the PEG chain is detached from the CA, which becomes less water soluble. This compound and control compounds were successfully tested in an animal model bearing two tumors with different levels of MMP-2 activity.
44
A matrix metalloproteinase expressed on the surface of invasive tumour cells
Hiroshi Sato, Takahisa Takino, Yasunori Okada et al. · Nature · 1994 · 2.6K citations
Metastatic potential correlates with enzymatic degradation of basement membrane collagen
Lance A. Liotta, Karl Tryggvason, Spiridione Garbisa et al. · Nature · 1980 · 1.8K citations